510(k) K864442

NORFLOXACIN SUSCEPTIBILITY POWDER by Merck, Sharp & Dohme — Product Code JTT

K864442 is an FDA 510(k) premarket notification submitted by Merck, Sharp & Dohme for the device "NORFLOXACIN SUSCEPTIBILITY POWDER". The FDA issued a decision of Substantially Equivalent on December 11, 1986. The device falls under product code JTT (Susceptibility Test Powders, Antimicrobial), a Class II device regulated under 21 CFR 866.1640. Merck, Sharp & Dohme has at least 3 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
December 11, 1986
Date Received
November 12, 1986
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Susceptibility Test Powders, Antimicrobial
Device Class
Class II
Regulation Number
866.1640
Review Panel
MI
Submission Type